Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 06/23/2025 3:20:56 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 2884
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
49164
As you said Brilacidin does not have systemic
(2)
RusticBum
09/23/2018 4:17:29 PM
49163
Well here we are folks at the last trading week
(12)
Kelt
09/23/2018 1:42:25 PM
49162
Ahhh Yes. A little word twisting here,a little
(2)
Kelt
09/23/2018 1:40:12 PM
49161
Menon is in his mid-70's and was already on half
Drano
09/23/2018 1:36:55 PM
49160
Is it possible that Menon's termination has
smokenhot
09/23/2018 1:18:21 PM
49159
We have only people's word for it that they are
(2)
Drano
09/23/2018 12:58:15 PM
49158
That is incorrect. Bril-OM PREVENTS lesions from
(6)
Drano
09/23/2018 12:40:39 PM
49157
If both Galera's GC4419 and Brilacidin get
(1)
RusticBum
09/23/2018 11:57:00 AM
49156
Accusing long term investors of being short multi
(2)
bejamin
09/23/2018 11:42:25 AM
49155
It's always good to have more than one treatment
(3)
Drano
09/22/2018 3:41:30 PM
49154
Could be a second line treatment after B-OM was
Trading Pro Broker
09/22/2018 3:36:35 PM
49153
NO way will an insurance company pay for that
(2)
smokenhot
09/22/2018 3:24:06 PM
49152
He's accusing long-time posters of being
(5)
Drano
09/22/2018 2:27:16 PM
49150
Take a look at Galas OM drug. Its
(1)
Trading Pro Broker
09/22/2018 1:38:41 PM
49149
Id like to see Leo take half his compensation
(2)
Commando911
09/22/2018 1:19:15 PM
49148
I have never heard of a long multi-identity in
(2)
petemantx
09/22/2018 1:10:28 PM
49147
Your right. That would be
Trading Pro Broker
09/22/2018 11:11:42 AM
49146
A reminder on how to use the Ignore feature:
Drano
09/22/2018 11:02:08 AM
49145
It's typical of many companies to have a large
(4)
Drano
09/22/2018 11:00:23 AM
49144
Multi identities on both sides create so much
(2)
bejamin
09/22/2018 10:59:06 AM
49143
I dont think it is a surprise. If it surprises
Trading Pro Broker
09/22/2018 10:48:51 AM
49142
Glad you're not running the company!
(1)
bejamin
09/22/2018 10:43:09 AM
49141
really, it is better not to respond to trolling
(1)
Drano
09/22/2018 10:00:01 AM
49140
So you think IPIX will begin testing on autism,
(1)
smokenhot
09/22/2018 9:01:20 AM
49139
Well seeing as you came from Yahoo I can
bejamin
09/22/2018 5:10:05 AM
49138
I don't know why this comes as any surprise. Dr.
(12)
Drano
09/21/2018 9:59:42 PM
49137
Yup 1 month here and 5 years on Yahoo. Maybe you
(4)
smokenhot
09/21/2018 9:19:33 PM
49136
No they have not. IPIX has other pre clinical
bejamin
09/21/2018 8:48:07 PM
49135
They have ALL gone thru Pre Clinical. What don't
smokenhot
09/21/2018 8:25:49 PM
49134
To bring new drugs online. IPIX has other drugs
bejamin
09/21/2018 7:37:42 PM
49133
Why would they restart R&D? They are a clinical
(2)
smokenhot
09/21/2018 6:31:27 PM
49132
Arent 18M of those options? Cant exercise
Trading Pro Broker
09/21/2018 6:25:43 PM
49131
As of 6/19/18 Menon has over 33M reasons to see
(1)
Mo
09/21/2018 6:06:58 PM
49130
Totally agree. He'll probably get board payments
incubus
09/21/2018 6:04:21 PM
49129
14% marked today! Go IPIX!!!
(1)
AlanC
09/21/2018 5:53:25 PM
49128
I wondered why he needed to hang around. His work
Trading Pro Broker
09/21/2018 5:52:29 PM
49127
I think scgmck1's post got spell checked from
(2)
Mo
09/21/2018 5:39:37 PM
49126
Who's employment?
Loose Lips
09/21/2018 5:29:36 PM
49125
8K out on the company website. Says mean on his
scgmck1
09/21/2018 5:04:11 PM
49124
They are running out of time. Cover those shorts
incubus
09/21/2018 4:08:53 PM
49123
Close at .299 again? hahaha they just can't allow
Drano
09/21/2018 4:03:10 PM
49122
I agree but I am not expecting news until 9/30
(3)
AlanC
09/21/2018 3:54:18 PM
49121
No prisoners!
(1)
incubus
09/21/2018 3:42:55 PM
49120
Now that most have seen the bad-faith postings of
(6)
Drano
09/21/2018 2:05:07 PM
49118
It was well written. And seeing both Leo and Dr.
(2)
BooDog
09/21/2018 1:39:00 PM
49116
Emailed yesterday's PR to a couple of friends
(3)
AlanC
09/21/2018 1:00:39 PM
49115
Yeah, that crap gives me a headache. Maybe they
(5)
BooDog
09/21/2018 12:25:50 PM
49114
Any more ludicrous taunting of genuine investors
(2)
Drano
09/21/2018 12:21:48 PM
49112
Its a weekend. Deals can get done. Would be
(2)
Trading Pro Broker
09/21/2018 11:29:46 AM
49111
Anybody notice that Dr. B left off Hidradenitis
(1)
smokenhot
09/21/2018 11:03:08 AM
Newer
Older
Recent Articles
Sky Quarry Embarks on Innovative Digital Asset Strategy
Canada Nickel Unveils Promising Mineral Resource Estimates
Westgate Energy's Strategic Advances in Oil Production and Market Growth
Spectral Capital Expands Portfolio with 42 Telecom Acquisition
GIBO Holdings Innovates Monetization for Short-Drama Platforms
Palatin Advances Obesity Research with PL7737: Key Findings
Exciting New Bybit Promotion Offers 20,000 USDT Weekly Rewards
BlackRock Sees Significant Revenue Growth and AUM Increase
Innovative Partnership to Enhance Marine Retail Solutions
Breakthrough Advances in Weight Loss Solutions by Palatin
Western Copper and Gold's Essential ESE Project Update
Coveo's Strategic Moves: Renewing Your Investment Confidence
OSR Holdings Welcomes Dr. Niethammer as New CMO of Vaximm
PSEG To Share Insights on Q2 2025 Financial Performance
GIBO Click Achieves Milestone with DramaFlow Monetization Engine
Freightos Achieves Record Performance in Second Quarter
7-Eleven Unveils Flavorful New Menu for Summer Enjoyment
Mokas Coffee & Eatery Announces Exciting Franchise Plans
Rhode Island's New Law Shields Homebuyers from Unfair Practices
S&P Global and Anthropic Collaborate to Transform Financial Data Access
Eshbal Expands U.S. Market Reach with Strategic Moves
YMCA's Ongoing Recovery Empowered by Community Support
Navigating Uncertain Markets: Insights from M4Markets Podcast
Aurora Spine Engages at Prestigious Pain Management Conference
Maryland Court Victory Boosts MSP Recovery's Legal Efforts
Acumen Pharmaceuticals Partners with JCR for Alzheimer’s Therapy Development
Goodfood Market Corp to Announce Q3 Fiscal 2025 Results Soon
Flagship Communities REIT Declares July 2025 Cash Distribution
Strategic Sale of Nord Projects Unveiled by Mirasol Resources
Enthusiast Gaming Unveils Innovative LookBuilder Tool for Gamers
TopBuild Enhances Portfolio with Strategic Roofing Acquisition
Aquestive Therapeutics Advances Global Plans for Anaphylm™
Apellis Pharmaceuticals Showcases Promising Research at ASRS 2025
Perspective Therapeutics: Upcoming Q2 Results and Updates
GXO Logistics Forms Strategic Alliance with Sky Italia for Supply Chain Solutions
Luxury Redefined: Halekulani Introduces Premier Suites
Bitcoin's Price Surge and the Rise of Cloud Mining Services
CECO Environmental Prepares for Second Quarter Earnings Reveal
Goodfood to Share Exciting Financial Insights Soon
Wendy's Expands Global Reach with New Franchise Agreements
Accelsius Introduces NeuCool™ Liquid Cooling at Equinix
Mirasol Resources Completes Sale of Nord Projects for $2.5M
Freightos Achieves Record Transactions and Strong Growth Metrics
Adagene Provides Insights on Phase 2 Clinical Trial Plans
Exploring the Positive Impact of Valvoline Inc. in 2024
Explore the Highlights of the Emerging Growth Conference Now
Potential Market for ARAKODA® (tafenoquine) in Babesiosis
Discover Modern Living at Modera St. Paul in Dallas
Innovative Hydrogen Production by PyroGenesis for Steel Industry
Bio-Techne Partners with Spear Bio for Advanced Detection Technology